Analyst Research

Report Title Price
Provider: Wright Reports
Provider: Stock Traders Daily
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott announces FDA clearance for a new test to help physicians quickly and accurately diagnose diabetes

Monday, 14 Apr 2014 09:00am EDT 

Abbott Laboratories:Says that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test - which can aid physicians in diagnosing and monitoring diabetes and identifying people at risk for the disease - has received 510 clearance from the U.S. Food and Drug Administration. 

Company Quote

0.27 +0.58%
1 May 2015